Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulse high volume hemofiltration.

A Brendolan1, V D'Intini, Z Ricci

  • 1Department of Nephrology, Dialysis and Transplantation, St. Bortolo Hospital, Vicenza, Italy.

The International Journal of Artificial Organs
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

sRAGE: a prognostic factor for mortality in end-stage renal disease patients on dialysis.

Journal of biological regulators and homeostatic agents·2019
Same author

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.

Leukemia·2017
Same author

Elevated Levels of Procalcitonin and Interleukin-6 are Linked with Postoperative Complications in Cardiac Surgery.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2017
Same author

Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.

Thrombosis research·2017
Same author

Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.

Indian heart journal·2017
Same author

The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.

Critical care (London, England)·2016
Same journal

Therapeutic plasma exchange added to CRRT combined with hemoperfusion in wasp sting-associated AKI: A multicenter retrospective cohort study.

The International journal of artificial organs·2026
Same journal

Development of an early prediction model for ICU-acquired weakness in sepsis using PNI and SII.

The International journal of artificial organs·2026
Same journal

Foot care behaviors and perceived exercise benefits and barriers in diabetic hemodialysis patients.

The International journal of artificial organs·2026
Same journal

First clinical experience with citrate-anticoagulated CVVHD-based low-flow ECCO<sub>2</sub>R in severe hypercapnic respiratory failure.

The International journal of artificial organs·2026
Same journal

Carboxyhemoglobin levels for the detection of hemolysis in patients supported by left ventricular assist devices: A case series.

The International journal of artificial organs·2026
Same journal

Evaluation of arteriovenous fistulas of obtuse anastomosis in reducing thrombosis using computational fluid dynamics.

The International journal of artificial organs·2026
See all related articles

High volume hemofiltration (HVHF) effectively treats sepsis-induced organ dysfunction by removing inflammatory mediators. Pulse HVHF, a novel approach, shows promise for improved outcomes in critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Immunology

Background:

  • Sepsis syndrome is a leading cause of acute renal failure and multiple organ dysfunction in critically ill patients, associated with high mortality.
  • Immune dysregulation, characterized by a storm of inflammatory mediators, underlies sepsis-induced organ damage.
  • Extracorporeal blood purification offers a potential therapeutic strategy for sepsis by removing these mediators.

Purpose of the Study:

  • To describe the rationale and potential of "Pulse High Volume Hemofiltration" (Pulse HVHF) as an advanced extracorporeal blood purification technique for sepsis.
  • To evaluate the reliability, tolerance, and biological effects of Pulse HVHF.

Main Methods:

  • Review of existing literature and clinical data on High Volume Hemofiltration (HVHF) in sepsis.

Related Experiment Videos

  • Description of the "Pulse HVHF" technique, involving a daily 6-8 hour schedule followed by standard continuous venovenous hemofiltration (CVVH).
  • Assessment of hemodynamic effects, vasopressor requirements, and survival rates associated with HVHF and Pulse HVHF.

    • Main Results:

    • High Volume Hemofiltration (HVHF) has demonstrated significant benefits in sepsis, including improved hemodynamics, reduced vasopressor dependency, and enhanced survival.
    • Pulse HVHF represents a novel approach aiming for more efficient mediator removal and improved patient outcomes.
    • The technique is described in terms of its reliability, tolerance, and observed biological effects.

    Conclusions:

    • Extracorporeal blood purification, particularly HVHF, is a logical and effective approach for managing sepsis-induced organ dysfunction.
    • Pulse HVHF offers a promising advancement in sepsis treatment, potentially optimizing the removal of inflammatory mediators.
    • Further investigation into Pulse HVHF is warranted to fully elucidate its clinical utility and long-term impact on sepsis patient survival.